Finally, we assessed the expression levels of NCAPD3, c-Myc and E2F1 in 6 pairs of clinical CRC tissues and their corresponding adjacent normal tissues using Western blot assay. This evidence concerns the gene NCAPD3 and colorectal carcinoma.